General Information of the Compound
Compound ID
CP0481764
Compound Name
4,4-dimethyl-7-(2-methyloctan-2-yl)-1H-chromeno[4,3-c]pyrazole-6,9-dione
    Show/Hide
Synonyms
PMID27215781-Compound-37
    Show/Hide
Structure
Formula
C21H28N2O3
Molecular Weight
356.466
Canonical SMILES
CCCCCCC(C)(C)C1=CC(=O)C2=C(OC(C)(C)c3c[nH]nc23)C1=O
    Show/Hide
InChI
InChI=1S/C21H28N2O3/c1-6-7-8-9-10-20(2,3)13-11-15(24)16-17-14(12-22-23-17)21(4,5)26-19(16)18(13)25/h11-12H,6-10H2,1-5H3,(H,22,23)
    Show/Hide
InChIKey
XRDIITMVNDBOHN-UHFFFAOYSA-N
Physicochemical Property
logP
4.4609
Rotatable Bonds
6
Heavy Atom Count
26
Polar Areas
72.05
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 60148509
SID: 144076495
ChEMBL ID
CHEMBL3086346
Clinical Information about the Compound
Drug 1 ( PMID27215781-Compound-37 )
Drug Name PMID27215781-Compound-37
Company CONSEJO SUPERIOR DE INVESTIGACIONES CIENTICAS (CSIC) UNIVERSIDAD DE ALCAL DE HENARES UNIVERSIDAD COMPLUTENSE DE MADRID
Indication
Prostate cancer
Patented
Target(s)
Cannabinoid receptor 2 (CB2)
-
Cannabinoid receptor 1 (CB1)
-